Drugs / DDP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06190782 Background | Sep 2022 → Sep 2025 overdue | esophageal squamous cell carcinoma | Fudan University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DDP | “DDP25mg/m2, d1-3 or 75mg/m2,d1;q21d” NCT06190782 ↗ |